glp-1 employer coverage news october 2025 Drugs: Pulse Survey (U.S.) How Employers Can Manage GLP-1

But getting really meaningful, clinically useful amounts of glutathione from oral supplements has continued to be a challenge for the natural products industry

More recent research continues to suggest that there may be a signal worth paying attention to

Dhillon, M

Sources KFF health tracking poll May 2024: The publics use and views of GLP-1 drugs GLP-1 global forecast JP Morgan obesity drugs research Novo Nordisk market trends US weight loss drug prices vs other countries MIT report on GLP-1s Fortune Magazine report on Ozempic and Wegovy Yahoo Finance Novo Nordisk A/S (NVO) CNBC soaring demand for Wegovy and Ozempic FAIR Health white paper on obesity and GLP-1 drugs JAMA research letter on risk of gastrointestinal adverse events with GLP-1 drugs University of Queenslands risks and benefits of Ozempic Business model reinvention GLP-1 trends & impact survey